XEDITON - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
76687381
Word Mark
XEDITON
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2012-05-19
Filing Date
2008-03-05
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M10
Employee Name
MILTON, PRISCILLA W
Statements
Goods and Services
Vitamins, minerals, dietary supplements; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; pharmaceuticals, namely, pharmaceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; pharmaceuticals, namely, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; pharmaceuticals, namely, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; pharmaceuticals, namely, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; pharmaceuticals, namely, pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; pharmaceuticals, namely, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); pharmaceuticals, namely, pharmaceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, vitamin, mineral and herbal food supplements; pharmaceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; nutraceuticals, namely, nutraceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; nutraceuticals, namely, nutraceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; nutraceuticals, namely, nutraceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; nutraceuticals, namely, nutraceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; nutraceuticals, namely, nutraceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; nutraceuticals, namely, nutraceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; nutraceuticals, namely, nutraceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); nutraceuticals, namely, nutraceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants, antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; chemicals for medicinal purposes, namely, calcium, hydrogen, iodine, iron, sodium, super, zinc
Goods and Services
Providing consumer product information on pharmaceuticals, nutraceuticals, vitamins, minerals, dietary supplements, chemicals for medicinal purposes and medical devices and appliances
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2008-03-11
Primary Code
005
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2009-01-07
Primary Code
035
Correspondences
Name
CHRISTOPHER H. KOZLOWSKI; KOZLOWSKI & CO
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2007-09-05 | 1363594 | Canada | True |
Trademark Events
Event Date | Event Description |
2008-03-11 | NEW APPLICATION ENTERED IN TRAM |
2008-03-15 | APPLICATION FILING RECEIPT MAILED |
2008-06-15 | ASSIGNED TO EXAMINER |
2008-06-23 | NON-FINAL ACTION WRITTEN |
2008-06-23 | NON-FINAL ACTION MAILED |
2008-12-23 | PAPER RECEIVED |
2009-01-07 | ASSIGNED TO LIE |
2009-01-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2009-01-07 | AMENDMENT FROM APPLICANT ENTERED |
2009-03-04 | SUSPENSION LETTER WRITTEN |
2009-03-05 | LETTER OF SUSPENSION MAILED |
2009-09-05 | SUSPENSION INQUIRY WRITTEN |
2009-09-08 | INQUIRY AS TO SUSPENSION MAILED |
2010-03-08 | FAX RECEIVED |
2010-03-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2010-03-10 | AMENDMENT FROM APPLICANT ENTERED |
2010-03-12 | SUSPENSION LETTER WRITTEN |
2010-03-15 | LETTER OF SUSPENSION MAILED |
2010-09-17 | SUSPENSION INQUIRY WRITTEN |
2010-09-20 | INQUIRY AS TO SUSPENSION MAILED |
2011-03-17 | FAX RECEIVED |
2011-03-18 | ASSIGNED TO LIE |
2011-04-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2011-04-04 | AMENDMENT FROM APPLICANT ENTERED |
2011-04-08 | SUSPENSION LETTER WRITTEN |
2011-04-11 | LETTER OF SUSPENSION MAILED |
2011-07-20 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2011-07-20 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2011-10-11 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2011-10-18 | SUSPENSION INQUIRY WRITTEN |
2011-10-19 | INQUIRY AS TO SUSPENSION MAILED |
2012-05-19 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2012-05-21 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |